His Excellency Dr. Amin Hussain Al Amiri is the Asst. Undersecretary of Public Health Policy & Licensing Sector in UAE Ministry of Health & Prevention
Dr. Al Amiri got his Ph.D. and Ms. C. in Medical Science in 2003 from Faculty of Medicine; Aberdeen University in Scotland; UK.
He is responsible for the following departments at MOHAP:• Drug Dept.
• Empowerment & Health Compliance Dept.
• Organization, Licenses& Advertisement Dept.
• Public Health Policies Dept.

Dr Mariam Al-Jalahma was appointed by His majesty the King of Bahrain, in 2015 as the Chief Executive Officer of the National Health Regularity Authority in the Kingdom of Bahrain. She is as a member of the supreme council of health in Bahrain, and is appointed by the prime minister as a member in Academic accreditation Committee of the supreme council for Higher education in 2016.

Previous positions:

She was holding the position of Assistant Undersecretary for Primary Care and Public Health until 2015, and was a member of the Executive Board of The Health Ministers’ Council for GCC States until 2016.
A member of the Sura Council in 2000, and a member of the National Institute for Human rights. Dr. Al-Jalahma worked as an advisor for the world health organization in the fields of Adolescents and Non communicable diseases (NCDs).
Qualifications:· Arab Board certificate in Family & Community Medicine in 1990
· Higher studies diploma in medical education from Dundee University in Scotland in 1994
· Diploma in Health Care Management from Royal college of surgeon in Ireland in 2000
Honorees & medals
· In December 2011 she was awarded an honouree medal of efficiency by his majesty the king of Bahrain.
· In 1990 Awarded by the prime minister awards for leaders of Moharraq.
· In 2009 she was awarded by Her Highness Shaikha Sabika Bent Ebrahim Al-Khalifa the Princess of Bahrain and Chairperson of Woman Supreme council the award of National Woman day Celebration, the award is presented to women leaders in health.
· In June 2011 she is awarded by the regional office for eastern Mediterranean of the WHO the Anti-tobacco award of the region.
· Global award for health pioneers from UAE
· GCC leaders Award 2019

She holds B.Sc. Degree in Pharmacy from Jordan university of science       and technology, 2014, and she has seven years’ experience as a regulatory affairs pharmacist, three of them in a private sector including international company and drug store. Ms. Bayan joined Jordan FDA in 2018, as a pharmacist in the drug registration department – Originators/ biological and biosimilar Drugs Unit. In addition, she is an active member in the following committees at Jordan FDA:

• Committee for evaluation and registration of Originators/ biological and biosimilar Drugs.
• Post-approval changes committee

Myriam Razgallah Khrouf is a Professor of Pharmacology at the Faculty of Pharmacy (University of Monastir) and Director of the Unit of Pharmacy and Drug at the Ministry of Health in Tunisia.

Graduated from the Faculty of Pharmacy of Monastir and specialist in hospital and industrial pharmacy. She obtained her master in pharmacokinetic and she performed her interneship in pharmacology in Tunisia and in France, mainly within the federation of pharmacology at Marseille.

After a short experience as project manager in clinical trials in a multinational pharmaceutical laboratory in France she was appointed as pharmacokinetic assessor within the Drug French Agency « ANSM » (formerly called AFSSAPS).

In 2011 she came back to Tunisia to start her hospital-university career, with a large experience in hospital pharmacy department.

In 2016, with a multidisciplinary team composed of teachers, practitioners, economists, experts and industrialists, she set up a postgraduate diploma in pharmaco-economics within the faculty of Monastir pharmacy.

She have been committed in associatif work and was member of scientific board of Hopipharm (Francophone congres of hospital pharmacy) and was general secretary of the Tunisian Society of Oncology Pharmacy and member of the European Society of Oncology Pharmacy

In December 2018 she was appointed as director in the Unit of Pharmacy and Drug within the Tunisian Ministry of Health.

During the COVID Crisis she participated actively in the coordination of vaccine registration, in the enrollement of Tunisia in COVAX initiative and in the World Bank financement process.

Since 2020 she was elected to be member of the scientific council of the faculty of pharmacy of Monastir,in Tunisia.

She give several conference in regional and international congres and published several articles in the field of hospital pharmacy and pharmacology.

Since 2021 she became EML expert WHO.

External Medicine Dossier Assessor at Ethiopian Food and Drug Authority (EFDA) and

the Co-founder & Vice President of East Africa Regulatory Affairs Professionals Association (EARAPA). Mr. Nathan is also an assistant lecturer at the Addis Ababa University, School of Pharmacy, Department of Social Pharmacy and Pharmaceutics, Medicine Regulatory Affairs program.

He graduated from Clinical Pharmacy at the Addis Ababa University, and he’s currently finalizing his Master’s Degree in Medicine Regulatory Affairs.

I am an academician at the School of Pharmacy, in the Department of Pharmaceutics and Social Pharmacy.

Mrs. Nisreen Nassr is an Omani Senior specialist pharmacist, holding a Master degree in pharmaceutical Sciences. Her research was focused on Drug Discovery. In October 2015, she was appointed as the head of registration of Pharma products in the MOH, Oman. She is a member and secretary of the technical registration and Pricing committee in MOH Oman, Bioequivalence committee and the National Committee of Pharmacovigilance.  Her responsibilities include policy development regulatory affairs and capacity building. Prior to this role and since 2002, Mrs.

Nisreen handled various tasks as she was the Section of Controlled Medicines, GMP inspector, registration applications reviewer, and handled pricing. In 2007, she effectively contributed in the with WHO/HAl survey on medicines prices availability and affordability.

Dr. Donia Al Bastaki is the head of drug registration department with more than 17 years working experience in the pharmaceutical field, her area of expertise is regulatory affairs and pharmacovigilance where she contributed to the development of drug regulatory framework in Kuwait and GCC.

13 years’ experience in GMP inspection through which she inspected several international, regional, and local pharmaceutical manufacturing companies.

 Member of GHC Central Registration Committee since year 2007 till 2018 and contributed to setting the GCC Guidelines for Drug Registration as well as Stability, Bioequivalence and PIL GCC guidelines and others.

Member of the International Society of Pharmacovigilance and Kuwait deputy focal point for Uppsala Monitoring Center /WHO Collaborating Center for International Drug Monitoring.

She was assigned as Kuwait focal point with the League of Arab states in the field of Pharmacy and drugs and participated in the development of the Arab common Bioequivalence Guidelines.

Mr. Babiker has more than 20 years of experience in different fields of pharmacy practice including hospital pharmacy, community pharmacy, clinical pharmacy, drug information, patient safety, quality and risk management. He has presented many papers in international scientific conferences and published an original research article in reputable Journal.

Mr. Babiker is a pharmacist with initially a degree from Sudan, which he substantiated by doing additional internationally, recognized examinations. He has research experience through a Master program at Queens University Belfast in the United Kingdom. His research interests are in the areas of patient safety and pharmacy practice.

He has worked as drug information pharmacist at Hamad Medical Corporation, the principal health institute in Qatar, which contributed to his clinical knowledge and skills. Through his work for the Ministry of Public Health, especially the Community Pharmacies Steering Group for the National Health Strategy Project 1.6 Community Pharmacies Strategy and as vaccine registration supervisor, he also has experience with the development of policies.

In addition, Mr. Babiker is interested in sport activities; he was volunteering with Qatar Anti-doping Commission as a Doping Control Officer (DCO) since 2005. He participated in many and different sports activities in Qatar such as DCO, education & outreach program as well as DCO Venue Manager.

Salam Waiss is the head of Registration Department in Kurdistan Medical Control Agency (KMCA) / MOH Kurdistan Regional government of Iraq. He has 23 years of experience in Analytical & Regulatory fields. His approach to commit to standards is reflected on his management style & standards he binds the industry to. He contributed to the development of QC laboratory & Regulatory affairs Departments in KMCA. Therefore, awarded many times by Health Ministers for his profession in management and contributions in legislatives development.

He is the head of MOH Technical Committee since 2016, head & member of Manufacturers Registration Committee since 2008, Member of MOH Higher Committee of Medicine, Member of MOH Scientific Committee & a lecturer in Pharmacy College / Hawler Medical University.

Salam Waiss Holds pharmacy bachelor & industrial pharmacy master degrees from Pharmacy College / Baghdad University. He is a certified GMP auditor & member of European Compliance Academy since 2018.

Ali Alajme is the Digital Health Department Director in Ministry of Health and Prevention, and he played a vital role in leading national initiatives such as track and trace of medicine and UAE national unified medical record. He also lead Digital Patient Platform (Shefaa) which was awarded as the best Digital platform in World Summit of Information Society 2021. Ali Alajme was awarded as the winner of CIO of the year 2020 by the IDC and was chosen as top 50 CIO by IDG .inc in Middle East due to his role in leading technical vital projects in COVID 19 Pandemic. He is an Alumni of UAE leadership program (Qiyadat) in executive leaders, Mohammed Bin Rashid Government Innovation program and UAE government experience Exchange Trainers Program from Prime Minister Office of UAE. Ali Alajme has almost 16 years of experience in diverse sectors and he has a Master Degree in Business Administration from Higher Colleges of Technologies and a International Certified Balance Scorecard from Palladium.

Dr. Mona has a Bachelor degree in pharmdraceutical science and pharmaceutical manufacturing, Head of new medicine registration Unit. She is a member of registration and pricing technical committee, member of GCC medical device committee and she has worked on many tasks, worked as registration application reviewer (new, renew and minor variations), Medical device registered in GCC Council, GMP inspector and pharmacovigilance officer.

Dr. Eman Al-Awamleh was graduated from Jordan University of Science and Technology – Jordan; she received her BSc. degree in pharmacy in 1999. She worked as a Pharmacist at Community Pharmacies (1999-2009). She joined JFDA in 2010, at (Regulatory Affairs) Registration Department in Drug Directorate and became a specialist pharmacist in 2016. She is now a Senior Pharmacist and a head of Research and Scientific Advice Section in Drug Directorate. She had participated in many Registration Committees in JFDA, and she had many Presentations in many Conferences.

She has a BSc in pharmacy from Jordan University of science & technology in 2003 and a MSc in pharmaceutical quality assurance/quality control from Jordan University of science & technology in 2006. Pharmacist Rana was the former registration officer in Jordan pharmaceutical manufacturing company (JPM) and former to that she was the section head of Biological drugs, sera & vaccines in the registration department at JFDA. Currently, she is working as Head of clinical studies department.

Her previous work experience involved the assessment & review of CTD files of originator drugs, vaccines & biological drugs, Receipt & assessment of post approval changes regarding registered biological, originator drugs & vaccines, Intellectual properties & public health issues related to pharmaceuticals. She collaborated in the team for the preparation & review of the “Guidance for Registration of Biosimilars in Jordan” that was published in May,2015 as the national guidance in the official gazette. In addition, she reviewed & approved of the Clinical studies protocols for studies submitted to be conducted in Jordan.

Currently, her work responsibilities consist of Reviewing the applications for accreditation of centers (CROs), hospitals, laboratories (both diagnostic & analytical) involved in the conduct of clinical trials/BE studies, as well as the Inspection of the sites (for accreditation & during study conduct), to ensure continuous adherence to standards & requirements and reviewing therapeutic & nontherapeutic protocols to ensure compliance to requirements.

As Rafed’s Chief Commercial Officer, Ahmed Al Bastaki, with more than 28 years of professional experience encompass a wide scope in the field of healthcare & project management across the UAE and Internationally in both the government and private sectors. Having developed a wealth of knowledge & experience working on ambitious projects in the field of healthcare and supply chain management throughout his career, Ahmed’s duty includes steering major operational projects on behalf of Rafed and leading the Strategy Division, in addition to being a key driver in the collaborative effort across the company and its departments making sure Rafed is achieving above and beyond its objectives as a leading GPO.

In his prior role at Abu Dhabi Healthcare Services Company SEHA, Ahmed was responsible for leading, planning and monitoring major operational projects such as leading the complete transfer of medical services management of the Abu Dhabi Police Clinics to SEHA. He was a key member of the activation Steering Committee of Sheikh Shakhbout Medical City, the 743 bed state-of-the-art hospital in partnership with Mayo Clinic. He was also responsible for several other prominent supply chain projects including the SEHA Central Warehouse, SEHA Central PPE Procurement and Global Consumables Supply Chain, while also performing due diligence, setting strategies and effective optimization to ensure achieving the anticipated outcomes.

Qutaiba Al Manaseer, is a Public affairs professional drawing on more than 16 years’ experience in the biopharmaceutical industry. He is the Corporate Affairs Director for the Middle East and Africa.

Qutaiba serves in the Emirates Health Economics Society board as the Media and Public Relations Chairman.

Qutaiba holds a master’s in health economics from Barcelona School of Management, an MBA from the Swiss Business School, Switzerland and a bachelor’s degree in Pharmacy from the University of Jordan.

Baha AbuSalem is the Program Director of Tatmeen at EVOTEQ. Tameen, an initiative of the Ministry of Health and Prevention, is a highly advanced track and trace platform for pharmaceuticals and medical products based on EVOTEQ’s SmartTrack solution. This program will ensure the protection of public health and improve the security of healthcare at all stages.

A seasoned IT executive, AbuSalem has led large-scale projects in several verticals including government, telecommunications, transportation, and logistics. He has been driving innovation and delivering value-added experiences to companies through new and relevant technologies. AbuSalem holds an MBA from the University of Strathclyde, UK.

BSc in Pharmacy from Jordan University, 1991

MSc in drug analysis from Monastir University, Tunisia, 1998

PhD in Pharmaceutical sciences from University of Lille II, France, 2005. PhD thesis was awarded with distinction and it was nominated for “State Prize” at the Pharmaceutical Academy in Paris.

I have been working in the pharmaceutical industry for around 30 years. Joined Hikma Pharmaceuticals in 1991 and worked in different technical departments, with many years of hands-on experience in the formulation and process development, as well as analytical development of oral and injectable generic products. I held the position of Technical Director in Medicef (a newly established sister company for Hikma in Tunisia) for seven years, where I established all the technical departments: QA, QC, Product Pipeline, technical transfer and Regulatory Affairs. I also headed the Research and Development – Injectables department in Amman for around 10 years and successfully developed and registered new generic products targeting global markets in USA, EU and MENA.

Currently, I am heading the Regulatory Affairs activities in the MENA region, contributing to the development of the Regulatory strategy as well as setting the required implementation plans and programs that ensure effective and efficient function’s performance to best serve business needs across the region; while overseeing the Regulatory Affairs operations considering compliance with the internal and external policies and legislations, including submissions of new products in the pipeline and the maintenance of the existing portfolio in more than 14 countries in the MENA region, with local regulatory affairs teams in the majority of these countries. Work closely with health authorities and work on shaping the regulatory environment through liaising with the local agencies, local pharmaceutical organizations and associations and other stakeholders.

Other Activities in the Educational Field:

Jordan University of Science and Technology-Deanship of Scientific Research:

• Member in the “Scientific Research Committee” during the scholar year 2019-2020.

Yarmouk University:

• Member in the Faculty of Pharmacy board during the scholar year 2018 – 2019.

Jordan University of Science and Technology (JUST) & Yarmouk University:

• Deliver lectures to 5^th year Pharmacy students on the application of certain concepts and technologies in the pharmaceutical industry, focusing on bridging the gap between theorical knowledge and practical application (started in 2017 till now).

Jordanian Association for Pharmacists:

Received an appreciation and recognition award from the “Jordanian Association for Pharmacists” for the significant contribution to the development of pharmaceutical industry in Jordan (March 2019).

Jeffrey P. Kemprecos, BA, MA, MIBS, is Director of Communications, Government Affairs & Market Access at GSK, a globally-leading healthcare company.

Mr. Kemprecos is based in Dubai, United Arab Emirates, where he leads GSK’s policy advocacy across a wide range of health and pharmaceutical industrial issues.

The scope of this work includes healthcare reform, intellectual property and trade-related issues, access to innovative medicines and vaccines, and regulatory harmonization.  Policies and legislation affecting competition, investment and innovation in the pharmaceutical sector constitute a primary focus.  Public policy work comprises two complementary missions—advocating legislation, regulations and policies that advance human health and strengthen the innovative medicines sector.

Mr. Kemprecos has worked in the innovative biopharmaceutical industry across a variety of countries and regions for almost 30 years, including the Eastern Europe, Middle East, Africa, Latin America and Asia/Pacific regions, leading government affairs, public policy, communications and market access teams responsible for up to 140 countries.

Mr. Kemprecos is currently serving in his second term as Chairman of the Intellectual Property Committee for the Pharmaceutical Research & Manufacturers Association in the Gulf (PHRMAG), Leader of the PHRMAG DOH Engagement Group, and is a member of the U.K. Business Council’s Healthcare and Life Sciences Working Group and the US Chamber of Commerce Gulf Business Council and Oman American Business Council. He also serves on the Abu Dhabi DOH Undersecretary’s Healthcare Council.

Mr. Kemprecos is a native of Massachusetts.  He speaks Arabic, English, Turkish and French.  He is the father of 3 vivacious daughters and an avid fan of vintage automobiles.

Nawel Boukhatem with 13 years experience within the pharmaceutical industry in regulatory Affairs across 4 different regions Middle East, Egypt & South  Africa & North Africa. Nawel  is currently the Head of Regulatory Affairs for Middle East region and sitting in strategic discussion within ICMEA (India -Middle East-Maghreb, Egypt & South Africa, UCC & Turkey)  in Takeda pharmaceuticals  Company Limited (TSE:4502/NYSE:TAK) a global, values-based, R&D-driven biopharmaceutical leader with headquarters in Japan, committed to bringing better health and a brighter future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on the following therapeutic areas: Oncology, Gastroenterology, Rare Genetic & Hematology diseases, Neuroscience and globaly Plasma- Derived Therapies and Vaccines.

Before joining Takeda Pharmaceuticals company, Nawel was Regulatory Affairs Associate Director at Shire pharmaceuticals for Middle East and Africa before Takeda acquisition.

Prior Shire Nawel was regulatory affairs manager at Baxter pharmaceuticals for 3 years.

• She is a strong Regulatory Business Partner driver for results and a team player in any project she is part of it to enable different product launches and business expansion in fastest but in safer manner to help our patients across our countries to access to innovative products ; being energetic self-motivated person who spreads positive energy in any team she is part of;
• Nawel, inspires her colleagues and develop her team to perform at their best by building a positive work environment for talent development and growth, living their personal values in everything they did and giving back to patients.
• She enjoys working with diversed individuals from different cultures and disciplines including remote teams, learning new ideas and coaching others to address requirements from diverse stakeholder groups, including internal business partners, external suppliers and governmental organizations.
• Nawel sets high standard of results for her self and the team and succeeds to get their engagement and commitment.
• She has an excellent knowledge of pharma environment, regulations in Middle East and North Africa countries;

A pharmaceutical industry executive with more than 18 years of experience in both public and private Pharmaceutical Sector. Pharmacist by education, obtained master’s degree in public policy from the American University in Cairo

Led key initiatives in development and implementation of pharmaceutical regulations, planning and implementation of Health system reforms, and shaping regulatory policy.

As a former General Director of health products and Biopharmaceutics Registration Department, represented Egyptian Drug Authority in regional and international scientific and policy discussions with Health Agencies and WHO. Held other several key positions in the public pharmaceutical sector such as Director for the Pharmaceutical Supply Reform National Program and Policy Technical Office Director.

Led and coached big teams, taught pharmaceutical policy and regulations, and inspired and motivated young professionals to accomplish and grow.

Innovation Ambassador and Certified Speaker Coach

Founder in STEM her Up, STEM mentoring foundation for women and girls in Egypt

Ibrahim is currently the Regulatory Affairs Director of gulf countries (UAE, Kuwait, Qatar, Oman, Bahrain & Yemen) at AbbVie for more than 7 years.

Ibrahim started his career back in the year 2004 with Amman Pharmaceutical industry as a microbiologist analyst in the quality control unit, Ibrahim then moved to Tabuk Pharmaceutical Company local Saudi company, then moved to Hospira in UAE as a regulatory affairs covering MENA region.

Prior to joining AbbVie, he worked in regulatory affairs at DANONE Baby Nutrition

Ibrahim has more than 17 years of experience in the Regulatory affairs and Quality control field.

Ibrahim holds a Bachelor’s degree in Biological Sciences from Jordan University in Amman.

Amani Mansour is currently the Head of Regulatory Affairs, Gulf cluster in Pfizer. She has  over 12 years of experience in Regulatory Affairs (RA) across the pharmaceutical industry and governmental sector. She  joined Pfizer in 2011 and handled different roles within the regulatory team in Pfizer starting with above country role supporting Africa middle east region moving to an in-country role where she was leading the regulatory team within gulf and levant and Currently Amani is heading the regulatory affairs organization within Pfizer gulf.

She is also an active member within the Gulf trade association and is currently the Regulatory Affairs Working Group (RAWG) Co-Chair and is leading the Digitalization taskforce within Middle East Regulatory Network group.

Before joining Pfizer, Amani worked with the Ministry of Agriculture in Lebanon as Regulatory Affairs specialist.

Amani graduated from faculty of science in Saint Joseph University in Lebanon and holds 2 Master’s degree in Food Chemistry & Agro-economics.

Hala Abu Ghazalah, Head of Regulatory Affairs, Africa & Middle East
Pfizer Biopharmaceutical Group with 25 years of experience in Regulatory Affairs, External Affairs, and Marketing, supporting various healthcare categories.
Pharmacist by education, licensed in both UAE and Canada.

Lamis Youssef is the Senior Regulatory Affairs Manager, Gulf cluster in Pfizer. She has over 11 years of experience in Regulatory Affairs (RA) across the pharmaceutical industry. She joined Pfizer in 2016 as Regulatory affairs manager handling Africa middle east region for a diverse portfolio & was responsible for the Regulatory management of Hospira acquisition within Africa middle east region. In her current role Lamis is handling multiple therapeutics areas for innovative portfolio.

She is also an active member within the Gulf trade association and is currently leading the Trak & Trace and e-labelling taskforce within Regulatory Affairs working group.

Before joining Pfizer, Lamis worked as regulatory affairs for J&J medical devices and  Julphar, prior joining regulatory she had different roles working as production and quality assurance expert in different pharmaceutical companies in Egypt including Sigmatec and GSK.

Lamis graduated from faculty of Pharmacy 6^th October university, she has a six sigma green belt certificate and she is currently pursuing her MBA.

• Global Head of Clinical Research and Head of R&D for MENA at Hikma Pharmaceuticals with more than 30 years’ experience in Pharmaceutical Industry Worldwide.
• MSc Pharmacy University of Iceland
• Previously worked at TEVA, Allergan, Watson and Actavis
• GCP training from the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom 2017
• Executive Coaching from SuTra Coaching, Belgum 2016
• Leadership for Leaders University of Iceland 2015
• Monitoring of Clinical studies – Barnett international, Needham, Massachusetts, USA 2012
• Bioanalytical Monitoring – PharmaSys Inc. Cary, North Carolina, USA 2011
• Responsible for the planning, conduct and management of Hikma clinical endpoints studies and Bioequivalence studies Worldwide
• Responsible for Developing Hikma products for the MENA region
• Outside of work, special interest for football and chess

• Senior Clinical Research Manager at Hikma Pharmaceuticals with more than 26 years’ experience in Pharmaceutical Industry in MENA region.
• BSc Pharmacy-Jordan University of Science and Technology, MBA-University of Leicester
• Certified Project Management Professional (PMP) since 2007
• Certificate in Clinical Research-Harvard Medical School
• Responsible for the planning, conduct and management of Hikma clinical endpoints studies and Bioequivalence studies in MENA region
• Areas of special interest include Hematology and Oncology, Biosimilars
• Active Volunteer in Atfaluna Association for Children Medical Coverage
• Inspired daily by my family. In my free time, I like to exercise and read.

Rami Habbal is the Chief Executive Officer of GS1 UAE and serves on its Board of Directors. His appointment in 2020 followed almost a decade with the organization in which he was responsible for the organization’s growth and digital transformation.

Rami brings 25 years of experience in leadership and operational management. He has spearheaded the building of long-term strategic relationships with government authorities and industry organizations. His efforts have earned him recognition as a leading voice in the adoption of GS1 standards across the GCC region.

Rami is part of several government committees and advises authorities on various topics related to global standards, digital transformation, and traceability.  Rami is also an active participant in the regional entrepreneurial community, where he serves as a mentor and a board member for several start-up companies. He is a strong advocate of digital transformation through the adoption of standards

Sattam Turky Alghodyyr began his career as a pharmacist at King Khalid Hospital, AIMajma’ah, but soon moved to the Saudi Food & Drug Authority gaining unparalleled experience in the Bioequivalence, while also establishing himself as an expert inP harmacovigilance.

In 2016 he started at Saudi Pharmaceutical Industries and Medical Appliances Corporation-SPIMACO as the Pharmacovigilance and Bioequivalence Manager where he is now Director of Regulatory Affairs.

Sattam is the Founding Member of the Pharmaceutical Industry Association PIA, Member of the Board of Directors ARAC Healthcare Oct 2018 and a Committee member representing SPIMACO on the National Committee for Pharmaceutical Industries NCPI

He am a regional Quality Director and member of strategic global quality team with over 21 years of diversify experiences in quality, supplier/EMO quality, manufacturing, commercial affiliates and distribution within the Medical Device and Pharmaceutical industries . His quality experience was acquired in the United States, GHC region and China. This enabled me to acquire an extensive experience and knowledge in the implementation of a robust Quality Management Systems in accordance to USFDA, Health Canada, SFDA GMP, Medical Device regulations. He has a track record of outstanding HA inspection results.

He worked closely with various business partners in leading new products launch, geo-expansion, technology transfer and Procurement projects transition to outsourcing operations in the USA and China effectively with track record for remaining within the project timelines/cost and compliance.  He transformed many company’s business culture to foster the required Multinational quality culture to improve overall processes and support business strategic plans.

Furthermore, He lead the development and optimization of QMS for internal manufacturing sites, commercial affiliates, EMO business partners, distribution centers and new acquisitions to enhance operations excellence & compliance level. This was achieved by using practical knowledge and expertise to integrate lean manufacturing principles (kaizen tools) within a regulated environment, assuring Quality System compliance and harmonization, reducing product defect rate and achieving product cost avoidance. Recently, he was appointed to lead the global initiatives to develop strategic quality 4.0 digitalization roadmap which expect to enhance the internal capabilities by apply proactive quality as part of operational excellence program.

Varun offers Management Lead for Forge Track & Trace in Honeywell. Prior to Honeywell, he has worked with GE for their digital solution business and Nokia Siemens Networks for the communication technology business. In addition, he is an Alumni of the prestigious “Commercial Leadership Program” from GE. As for his education, he has a Bachelor of Electronics for NIT Surat, India and MBA in Marketing from IMT Ghaziabad, India. He has 11 years of Diverse experience in Industrial software solutions in Logistics, Connected Industrial and Transportation domain.

He is the Head of Serialization & Digital Enabling, Manufacturing Systems, Global Engineering at Takeda Pharmaceuticals, and Owns UPI (Unique Product Identifier process and system) and DA (Digital Authentication) process end to end to ensure compliance and patient protection, He Drives business value beyond pure compliance to leverage technology implemented Drives new technology to support DA and UPI/Track and Trace initiatives and Ensures new technology is embedded in our standard equipment in collaboration with head technology. Mr. Michael also monitors and improves OEE related to UPI/DA to ensure supply to patient. Previously he was the Cross Divisional Program Leader, Serialization & Tamper Evident at Novartis, and he was the Leader of a global USD$258M program spanning across 37 sites and 250 CMOs worldwide. He was also responsible for the design and definition of standardized templates coving Serialization & Product Tracking and Tamper Evident Packaging processes across the entire Novartis domain.

Dr. Eslam Abdo holds bachelor’s in pharmacy. After graduation he got postgraduate Doctor of Pharmacy Degree. Dr. Eslam has broad knowledge in the international drug regulatory affairs. He joined MOHAP, UAE in 2018 as a Regulatory Affairs Specialist in Drug Registration Department.
He covers many areas in his current role including New Drug Registration, Renewals and minor variations applications. Dr. Eslam is participating in many guidelines being issued MOHAP.

With over 20 years of corporate Market Access, Regulatory Affairs and Regional Management, Dr. Marielouise Abi Hanna, PharmD, spent her career in Pharma, Biotech and Generics both in Global and Regional roles throughout International Regulatory Affairs, Quality, Medical and Market Access, for major Multinationals among which GlaxoSmithKline and Novartis’ Sandoz business unit.
She founded The Reg.Cloud in 2018, a Pharma consultancy that specializes in Due Diligence and Audits for Merger & Acquisitions, Market Access and Regulatory Programs across the product lifecycle. The Reg.Cloud supports Small to Medium-sized Pharma Enterprises as well as established Multinationals to expand their geographical coverage, with a primary focus on Middle East, Africa, Asia Pacific, CIS and Eastern Europe.

Yousra a Regulatory Affairs and Commercial & Distribution Quality Assurance Head with over 16 years of diversified experience from various leadership positions in Regulatory Affairs and Quality Assurance within Health Authority as well as multinational organizations at both regional and local levels.

Yousra is currently leading Abbott-Gulf & Emerging Markets Regulatory Affairs & Quality Assurance. In her role in Abbott Established Pharmaceutical Division; Yousra is responsible for setting Regulatory Strategies for New Product Introduction, Geo-expansion, Licensing & Acquisition, Localization, Life cycle management, enhancement of promotional model, as well as RA risk mitigation and regulatory compliance.

Neeraj Pant is Co-founder and director of DDReg Pharma – A global Regulatory and Pharmacovigilance Services organization. Neeraj is a Proven Regulatory, Medical Affairs & Clinical Research executive with consistent achievement in identifying growth opportunities, delivering sustainable competitive advantage and driving quality compliance. Before DDReg Neeraj has had Strong corporate experience of 21 years of handling and heading RA functions with leading global pharma organizations like Ranbaxy Labs Ltd (erstwhile), Pfizer, Johnson & Johnson & RB and managing different spheres of regulatory affairs like Rx, OTC, Cosmetics, Food Products, Medical Devices & Household Pesticides. Repeatedly appointed into senior leadership roles based on demonstrated success in defining and executing short and long term strategy, directing product development, regulatory strategies and clinical research initiatives and leading regulatory teams. Astute business and regulatory strategist with expertise in optimizing P&L, building and motivating top-performing teams and building relationships with Key Opinion Leaders.

Puneet Kumar is a Supply Chain & Logistics leader, and is passionate to augment healthcare supply chain by designing digital and innovative solutions.
He is an MBA, has an Engineering background, and believes in the principles of Lean, Six Sigma and agile methodologies.

He has diverse experience across various geographies as well as various industries like Shipping, Transportation, Electronics, Manufacturing, Oil & Gas and Healthcare.

He is currently with Roche Pharmaceuticals, based in Dubai UAE, as Supply Chain and Logistics Lead with additional roles as:
• Digital Transformation Lead, as well as
• as Supply Chain Business Partner for CMA
[CEETRIS -Central & Eastern Europe, Turkey, Indian Sub-continent, Middle East and Africa]

He has vast experience in creating innovative digital supply chain solutions as well as models and processes for Working Capital and Inventory management, Value chain management, Process re-engineering, Lean methodology and Logistics & Supply Chain Management of Temperature controlled products and associated machineries.

He is a highly motivated and passionate individual who wants to make a difference in peoples’ life. Continual and sustainable growth is his true calling. Currently he is looking to explore and utilize the potential of digitization in Supply Chain, fostering ecosystem-networked approach with End-to-End optimization mindset to make a difference in patients’ and caregivers lives.

Om Kolthoom Mahmoud Weisy is a Senior Regulatory affair, Pharmacovigilance specialist & licensed pharmacist at Pharmalink drug store with a demonstrated history of working in a pharmaceutical drug store. She is responsible for the registration of all products categories (conventional, GSL, Medical devices) in the United Arab Emirates and GCC countries. Dealing with US & European markets requires strong knowledge of EMA, US FDA & ICH regulations.

Graduated from the University of Sharjah in 2018 with an excellent and honor degree. Currently, she is doing her master’s degree in pharmaceutical sciences – Pharmaceutics. She is collaborating with the local health authorities to do an epidemiological study on Helicobacter pylori, in addition, she is conducting different projects at the laboratory level. Familiar with Pharmacy management & training skills

Dr. Rabab Tayyem is the Executive Director and CEO of ACDIMA BioCenter. She has a BSc in Pharmacy in addition to MSc in Analytical Toxicology and obtained her postgraduate PhD degree in Drug Design and Medicinal Chemistry. Dr. Tayyem has more than 20-year experience in clinical and bioequivalence studies, after starting her career in pharmaceutical industry. Working in ACDIMA BioCenter for more than 17 years she culminated the experience from start and worked in different functions articulated in the core of regulatory sciences related to bioequivalence and bioavailability studies.

Inas is a holder of Pharmacy diploma, and Master in EU and International Regulations and Healthcare Laws from Paris V University.

Inas has 17 years expertise in the European and Emergent markets regulations; she worked for various MNCs, and currently she is heading the regulatory department for MEA region in Novartis.

Her focus and interest is the Healthcare reforms and legislations, and policy shaping with main objective to accelerate patient access to innovative medicines.

Inas chaired the EFPIA regulatory group for 3 years; And she chaired the PhRMA association regulatory group for 4 years. She also chaired the program committee for the Middle East regulatory conference in 2019, and actively participating as a speaker in regional and international conferences.

She is the Director Regulatory Affairs at Viatris, as an organization dedicated to empowering people worldwide to live healthier at every stage of life. Ms. Doa is passionate about raising awareness around cardiovascular, mental health,  respiratory diseases and diabetes and believes in shaping policy & regulations enhancement to improve patient access to their medicines & building trusted partnership with Board of Health.

Bringing 23 years of diversified experience in different multinational Pharmaceutical, Medical, Consumer Health companies (MSD, Novartis, Sandoz, Paul Heartmann, GlaxoSmithKline Consumer Health, Pfizer & Viatris) within sales, marketing, corporate affairs and communications & regulatory affairs departments, with proven success in engaging with different environments covering government, corporate, business and trade associations, directing and implementing regulation changes, policy shaping and corporate process enhancement.

Doa holds a bachelor’s degree in pharmaceutical science- Egypt.

Simge Sasmaz is a principal aligned to Consulting Services in IQVIA based in Dubai. Simge has strong expertise in consulting supporting local, regional, and international clients within the healthcare, including pharmaceutical companies, consumer healthcare clients and financial institutions. With over 15 years of pharma & strategy consulting experience in developed and emerging markets, she successfully led a wide range of consulting engagements, including geographic and therapy area expansion strategies, assessments for new therapies, portfolio prioritization, commercial due diligence, identification and evaluation of licensing opportunities and commercial design. Simge holds a BSc degree in Economics from Boğaziçi University and a masters’ degree in Economics from Sabancı University.

Zeeshan Ahmed is the Founder and CEO of CosmoTrace Limited, U.K, a leading Life Sciences Consulting organization that offers Serialization & Traceability strategy consulting, implementation & integration services to the Pharma and other highly regulated industries.

He is an experienced Program Director, specialising in deploying Traceability and Serialization solutions globally. Prior to founding CosmoTrace, Zeeshan has worked across a broad spectrum of companies & sectors, including FMCG, IT and the Life Sciences.

She is the Regulatory Affairs Manager at Viatris Global Pharmaceutical Company.

Dr. Eman has 15 years diversity experience in regulatory affairs, quality assurance, pharmacovigilance & import/export pharma operation starting with Al Baker Distributor, UAE, expanding career professionalism to Responsible Quality Assurance Pharmacist with CHEMONICS Global Health Supply Chain (USAID Contractor) and with Valeant MENA

active member in RA & QA groups

Doctorate Degree in Toxicology-Algiers University (Algeria). Master Degrees in Quality Assurance and Quality Control.

A pharmacist with over 17 years of experience in both Pharmaceutical Industry within Middle East and Africa and Hospital Ground. Solid experience in Track and Trace including support to set up of global capabilities as well as impactful shaping of the dynamic legislative environment through active participation in the Track and Trace Taskforce; a key priority of the RAWG (PhRMAG).